BrightSpring Health Services plans a secondary offering of 15 million shares by certain stockholders.
Quiver AI Summary
BrightSpring Health Services, Inc. has announced a secondary stock offering of 15,000,000 shares of its common stock, initiated by certain stockholders including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and management members. All proceeds from the sale will go to the selling stockholders, as BrightSpring itself will not sell any shares in this offering. Following the offering, the company plans to buy back shares from the underwriter, with the purchase limited to 10% of the offering or up to $50 million. The offering is facilitated by BofA Securities, which will manage the sale of shares at current market prices. A registration statement for these securities has already been filed with the SEC. Additionally, the release includes forward-looking statements and a disclaimer regarding the risks and uncertainties related to BrightSpring's future performance.
Potential Positives
- BrightSpring Health Services is facilitating a secondary offering of 15,000,000 shares, indicating strong interest from stockholders, including notable affiliates like Kohlberg Kravis Roberts & Co. L.P.
- The company has authorized a planned share repurchase of up to $50 million, which could enhance shareholder value and indicate management's confidence in the company's stock.
- No shares are being sold by BrightSpring itself in the offering, demonstrating that the company is not diluting its own equity and is maintaining a solid capital structure.
- The offering is executed through a reputable underwriter, BofA Securities, enhancing the credibility of the offering process and providing access to broader capital markets.
Potential Negatives
- The secondary offering of 15,000,000 shares indicates potential dilution of existing shareholders' equity, which could negatively impact stock value and investor sentiment.
- The fact that no shares are being sold by BrightSpring itself suggests the company may not be in a position to capitalize from raising funds directly, which could signal financial limitations.
- The reliance on selling stockholders for the proceeds may raise concerns about management's confidence in the company's future performance and could affect shareholder trust.
FAQ
What is the recent announcement from BrightSpring Health Services?
BrightSpring announced a secondary offering of 15,000,000 shares of common stock by certain stockholders.
Who will receive the proceeds from the secondary offering?
The Selling Stockholders will receive all proceeds from the offering, as BrightSpring is not selling any shares.
What is the role of BofA Securities in this offering?
BofA Securities is acting as the sole book-running manager for the proposed secondary offering.
Is BrightSpring Health Services repurchasing any shares during this offering?
Yes, BrightSpring may repurchase up to 10% of the shares sold in the offering, or $50 million.
Where can interested parties obtain the preliminary prospectus for the offering?
Copies of the preliminary prospectus can be obtained from BofA Securities’ Prospectus Department via email or mail.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BTSG Insider Trading Activity
$BTSG insiders have traded $BTSG stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:
- GROUP PARTNERSHIP L.P. KKR has made 0 purchases and 2 sales selling 15,388,101 shares for an estimated $325,487,573.
- PHOENIX AGGREGATOR L.P. KKR has made 0 purchases and 2 sales selling 15,388,101 shares for an estimated $325,487,573.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BTSG Hedge Fund Activity
We have seen 159 institutional investors add shares of $BTSG stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 15,863,646 shares (-17.1%) from their portfolio in Q2 2025, for an estimated $374,223,409
- WALGREENS BOOTS ALLIANCE, INC. removed 11,239,996 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $265,151,505
- INVESCO LTD. added 2,946,811 shares (+47.7%) to their portfolio in Q2 2025, for an estimated $69,515,271
- FULLER & THALER ASSET MANAGEMENT, INC. added 2,722,772 shares (+inf%) to their portfolio in Q2 2025, for an estimated $64,230,191
- ROYAL BANK OF CANADA added 2,579,210 shares (+88938.3%) to their portfolio in Q2 2025, for an estimated $60,843,563
- VANGUARD GROUP INC added 2,394,053 shares (+36.1%) to their portfolio in Q2 2025, for an estimated $56,475,710
- BLACKROCK, INC. added 2,271,795 shares (+54.1%) to their portfolio in Q2 2025, for an estimated $53,591,644
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BTSG Analyst Ratings
Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 10/17/2025
- Morgan Stanley issued a "Overweight" rating on 10/14/2025
- UBS issued a "Buy" rating on 10/13/2025
- B of A Securities issued a "Buy" rating on 09/10/2025
- Wells Fargo issued a "Overweight" rating on 05/13/2025
To track analyst ratings and price targets for $BTSG, check out Quiver Quantitative's $BTSG forecast page.
$BTSG Price Targets
Multiple analysts have issued price targets for $BTSG recently. We have seen 5 analysts offer price targets for $BTSG in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Ann Hynes from Mizuho set a target price of $32.0 on 10/17/2025
- Erin Wright from Morgan Stanley set a target price of $32.0 on 10/14/2025
- A.J. Rice from UBS set a target price of $35.0 on 10/13/2025
- Stephen Baxter from Wells Fargo set a target price of $33.0 on 10/07/2025
- Joanna Gajuk from B of A Securities set a target price of $31.0 on 09/10/2025
Full Release
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, intend to offer for sale in a secondary offering an aggregate of 15,000,000 shares of common stock of BrightSpring. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering.
In addition, the Company has authorized, subject to the completion of the offering, the concurrent purchase from the underwriter, out of the 15,000,000 shares of common stock being sold as part of the secondary public offering, a number of shares having an aggregate purchase price of up to the lesser of 10% of the shares sold in the offering or $50.0 million at a price per share equal to the price per share to be paid by the underwriter to the Selling Stockholders. The underwriter will not receive any underwriting fees for the shares being repurchased by the Company. The closing of the share repurchase is conditioned on, and expected to occur simultaneously with, the closing of the offering. The offering is not conditioned upon the completion of the share repurchase.
BofA Securities is acting as the sole book-running manager for the proposed offering. The underwriter proposes to offer the shares of common stock, other than shares subject to the share repurchase, from time to time for sale in one or more transactions on the Nasdaq Global Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.
A shelf registration statement (including a prospectus) on Form S-3 relating to these securities was filed with the Securities and Exchange Commission on June 10, 2025 and became automatically effective upon filing. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering of these securities will be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus for the offering may be obtained from BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC, 28255-0001, Attn: Prospectus Department, Email: [email protected].
Forward Looking Statements
The statements contained in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on BrightSpring’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These expectations, beliefs, and projections are expressed in good faith and BrightSpring believes there is a reasonable basis for them. However, there can be no assurance that these expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional, or local economic, business, competitive, market, regulatory, and other factors, many of which are beyond BrightSpring’s control. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in BrightSpring’s filings with the SEC under caption “Risk Factors,” including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and subsequent other filings BrightSpring makes with the SEC from time to time. Any forward-looking statement in this press release speaks only as of the date of this release. BrightSpring undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws .
Contacts
Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
[email protected]
or
Media Contact:
Leigh White
[email protected]
502.630.7412